Substituted triazoles as sodium channel blockers

A compound represented by Formula (I) or (II):

• or a pharmaceutically acceptable salt thereof, wherein
• R1 is
• (a) H,
• (b) C1-C6-alkyl, C2-C4-alkenyl, C2-C4-alkynyl, any of which is optionally substituted with one or more of the following substituents:
• NRaRb, COOH, CONRaRb, or
• (c) —C(═O)Ra, COORa, CONRaRb;
• Ra is:
• (a) H,
• (b) C1-C6-alkyl, optionally substituted with one or more of halogen or CF3, or
• (c) CF3;
• Rb is
• (a) H, or
• (b) C1-C6-alkyl, optionally substituted with one or more of halogen or CF3, or
• (c) CF3;
• R2 is H or C1-4 alkyl;
• R3 and R4 each independently is:
• (a) H,
• (b) —C0-C4-alkyl-C1-C4-perfluoroalkyl or —O—C0-C4-alkyl-C1-C4-perfluoroalkyl,
• (c) halogen, or
• (d) —C1-C6 alkyl, optionally substituted with one or more of halogen or CF3;
• and
• R5, R6 and R7 each independently is:
• (a) H,
• (b) —O—C1-C6-alkyl, —O—C1-C6-alkenyl, —O—C1-C6-alkynyl, any of which is optionally substituted with one or more of halogen or CF3,
• (c) —C0-C4-alkyl-C1-C4-perfluoroalkyl, or —O—C0-C4-alkyl-C1-C4-perfluoroalkyl,
• (d) —O-phenyl, or —O—C1-C4-alkyl-phenyl, wherein phenyl is optionally substituted with 1-3 substituents selected from i) halogen, ii) —CN, iii) —NO2, iv) CF3, v) —ORa, vi) —NRaRb, vii) —C0-4alkyl-CO—ORa, viii) —(C0-4alkyl)-CO—N(Ra)(Rb), ix) and x) —C1-10alkyl, wherein one or more of the alkyl carbons can be replaced by a —NRa, C(O)—O—, or —N(Ra)—C(O)—N(Ra)—, or
• (e) halogen, —ORa, or phenyl wherein phenyl is optionally substituted with 1-3 substituents selected from i) halogen, ii) —CN, iii) —NO2, iv) CF3, v) pyrazolyl, vi) —ORa, vii) —NRaRb, viii) —C0-4alkyl-CO—ORa, ix) —(C0-4alkyl)-CO—N(Ra)(Rb), and x) —C1-10alkyl, wherein one or more of the alkyl carbons can be replaced by a —NRa, C(O)—O—, or —N(Ra)—C(O)—N(Ra)—.